Skip to main content

Advertisement

Table 4 Univariate and multivariate Cox proportional hazard regression analysis for DM patients

From: Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Clinical outcomes (n, %) Univariate multivariate
HR (95% CI) P HR (95% CI) P
MACE 1.245 (0.935–1.656) 0.133 1.252 (0.939–1.669) 0.126
 All-cause death 0.986 (0.407–2.389) 0.976 0.953 (0.387–2.351) 0.917
 Cardiac death 0.555 (0.128–2.412) 0.432 0.410 (0.089–1.879) 0.251
 Non-fatal MI 1.808 (0.992–3.295) 0.053 1.689 (0.913–3.122) 0.095
 Stent thrombosis 1.116 (0.419–2.974) 0.826 1.002 (0.370–2.714) 0.997
 Revascularization 1.205 (0.846–1.717) 0.300 1.215 (0.852–1.733) 0.283
  TVR 1.329 (0.843–2.096) 0.221 1.325 (0.835–2.101) 0.232
  TLR 1.495 (0.923–2.422) 0.103 1.453 (0.891–2.371) 0.134
 Stroke 0.681 (0.237–1.950) 0.474 0.731 (0.253–2.111) 0.563
Bleeding 0.748 (0.471–1.188) 0.219 0.727 (0.447–1.182) 0.198
 BRAC 2_5 0.710 (0.337–1.497) 0.368 0.705 (0.333–1.491) 0.360
 BRAC 3_5 0.554 (0.069–4.432) 0.578 0.563 (0.070–4.535) 0.590
  1. DM diabetes mellitus, G2-DES second generation drug-eluting stent, BP-DES biodegradable polymer drug-eluting stent, MACE major adverse cardiac events, MI myocardial infarction, TVR target vessel revascularization, BARC Bleeding Academic Research Consortium definition